يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"Hundebøl, Monique F."', وقت الاستعلام: 0.69s تنقيح النتائج
  1. 1
    Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer

    المؤلفون: Alves, Carla L., Ehmsen, Sidse, Terp, Mikkel G., Portman, Neil, Tuttolomondo, Martina, Gammelgaard, Odd L., Hundebøl, Monique F., Kaminska, Kamila, Johansen, Lene E., Bak, Martin, Honeth, Gabriella, Bosch, Ana, Lim, Elgene, Ditzel, Henrik J.

    المصدر: Nature Communications. 12(1)

    مصطلحات موضوعية: Medicin och hälsovetenskap, Klinisk medicin, Cancer och onkologi, Medical and Health Sciences, Clinical Medicine, Cancer and Oncology

    الوصول الحر: https://lup.lub.lu.se/record/39adea6b-cae3-4c48-a1a1-de5993002c76Test
    http://dx.doi.org/10.1038/s41467-021-25422-9Test

    View record in SwePub

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Publisher Correction:Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer (Nature Communications, (2021), 12, 1, (5112), 10.1038/s41467-021-25422-9)

    المؤلفون: Alves, Carla L., Ehmsen, Sidse, Terp, Mikkel G., Portman, Neil, Tuttolomondo, Martina, Gammelgaard, Odd L., Hundebøl, Monique F., Kaminska, Kamila, Johansen, Lene E., Bak, Martin, Honeth, Gabriella, Bosch, Ana, Lim, Elgene, Ditzel, Henrik J.

    المصدر: Alves , C L , Ehmsen , S , Terp , M G , Portman , N , Tuttolomondo , M , Gammelgaard , O L , Hundebøl , M F , Kaminska , K , Johansen , L E , Bak , M , Honeth , G , Bosch , A , Lim , E & Ditzel , H J 2021 , ' Publisher Correction : Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer (Nature Communications, (2021), 12, 1, (5112), 10.1038/s41467-021-25422-9) ' , Nature Communications , vol. 12 , ....

    وصف الملف: application/pdf

    العلاقة: https://portal.findresearcher.sdu.dk/da/publications/286977a2-bf68-450b-a6ec-cf4e8124a278Test

    الإتاحة: https://doi.org/10.1038/s41467-021-25901-zTest
    https://doi.org/10.1038/s41467-021-25422-9Test
    https://portal.findresearcher.sdu.dk/da/publications/286977a2-bf68-450b-a6ec-cf4e8124a278Test
    https://findresearcher.sdu.dk/ws/files/195681657/Open_Access_Version.pdfTest

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer.

    المؤلفون: Alves, Carla L., Ehmsen, Sidse, Terp, Mikkel G., Portman, Neil, Tuttolomondo, Martina, Gammelgaard, Odd L., Hundebøl, Monique F., Kaminska, Kamila, Johansen, Lene E., Bak, Martin, Honeth, Gabriella, Bosch, Ana, Lim, Elgene, Ditzel, Henrik J.

    المصدر: Nature Communications; 9/16/2021, Vol. 12 Issue 1, p1-1, 1p

    مصطلحات موضوعية: BREAST cancer, HORMONE therapy, PUBLISHING

    النص الكامل

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث